Israel’s case for cancer care doesn’t rest on volume or price alone — it rests on a specific, checkable claim: alongside the US and China, it’s one of only three countries in the world offering a domestically-developed CAR-T cell therapy program. That’s not marketing language, it’s a statement about where the treatment actually exists.
Why Patients Consider Israel for Cancer Treatment
A homegrown CAR-T program, not an imported one. CAR (chimeric antigen receptor) T-cell therapy — reprogramming a patient’s own immune cells to attack cancer — is currently only produced domestically in three countries: the US, China, and Israel. Hadassah Medical Center developed its own CAR-T therapy for multiple myeloma, with reported results of roughly 90% of patients showing improvement and 57% reaching remission. That’s a specific published outcome, not a general claim about “advanced technology.”
A dedicated oncology institute since 1977. The Sharett Institute of Oncology at Hadassah was Israel’s first comprehensive cancer center and functions today as a national and international referral point, taking in over 3,500 new patients a year from around the world.
JCI accreditation plus specialty-specific credentials. Hadassah holds Joint Commission International accreditation — the standard benchmark for evaluating a hospital abroad — alongside JACIE accreditation, which is specific to blood and marrow transplantation and cellular therapy programs. For a cancer patient, that second credential is the more targeted signal.
Real cost savings, even for advanced therapy. CAR-T treatment specifically has been quoted in the $90,000–$120,000 range in Israel against $400,000+ in the US — and cancer treatment generally runs 70–80% below US pricing across treatment types, not just the most advanced ones.
Where Care Actually Happens
Hadassah Medical Center, Jerusalem — university hospital and tertiary referral center with 130 specialized departments, JCI, ISO and JACIE accredited. Its oncology program treats over 40,500 hospitalized oncology and haematology patients a year as part of roughly 1.5 million patients treated annually across all departments, with more than 35,000 surgeries performed. Premium pricing, 4.8/5 rating from 2,800 reviews, English spoken alongside Hebrew, with a dedicated international patient program and translator coordinators.
This is Wellmap’s one verified entry point for cancer care in Israel — a single major academic center rather than a spread of competing private hospitals. That’s less choice than Turkey or Germany offer, but it’s the country’s flagship institution for the specific technology (CAR-T, immunotherapy research) that makes Israel worth considering in the first place.
What This Means in Practice
Israel makes the most sense for patients who:
- Have a diagnosis where CAR-T or immunotherapy is a realistic option — multiple myeloma and certain blood cancers in particular, given Hadassah’s published results
- Want a specialty-specific accreditation (JACIE) alongside general JCI certification, not just the general standard
- Are open to premium pricing that still runs well below US costs for the same advanced treatment
For cancer types where standard surgery, chemotherapy or radiotherapy is the whole treatment plan, Turkey, Thailand or the Czech Republic will cost less for broadly comparable outcomes — Israel’s case is strongest specifically where cutting-edge cellular therapy is actually indicated for your diagnosis. Ask your oncologist directly whether CAR-T or a similar advanced immunotherapy applies to your case before assuming Israel is the right fit.
What to Bring
- Pathology reports and imaging (CT, MRI, PET-CT) on CD/USB in DICOM format where possible
- Recent blood work and current medication list
- A referral letter or summary from your current oncologist
- Prior treatment and surgery records
Getting Started
Contact Hadassah’s international patient department to send records for review before booking travel — for advanced cellular therapy specifically, confirming eligibility on your records first matters more than for a standard procedure, since not every case qualifies.
See verified oncology clinics in Israel, or ask our AI assistant — describe your cancer type and whether immunotherapy or cell therapy has come up in your treatment discussions.
Sources: